Compare Mahindra Manulife Mid Cap Fund vs Invesco India Mid Cap Fund
Mahindra Manulife Mid Cap Fund
EquityMid Cap
Invesco India Mid Cap Fund
EquityMid Cap
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
2.02
1.86
NAV
₹38.50
₹225.58
Fund Started
08 Jan 2018
15 Feb 2007
Fund Size
₹5058.42 Cr
₹15748.83 Cr
Exit Load
Exit load of 1% if redeemed within 3 months.
Exit load for units in excess of 10% of the investment, 1% will be charged for redemption within 1 year.
1 Year
0.92%
-0.27%
3 Year
13.35%
19.62%
5 Year
12.85%
15.34%
Equity
97.27%
98.74%
Cash
2.73%
1.26%
Top 10 Holdings
Name | Assets |
|---|---|
The Federal Bank Ltd. | 3.42% |
Indusind Bank Ltd. | 3.19% |
Aditya Birla Capital Ltd. | 2.79% |
Coforge Ltd. | 2.65% |
Glenmark Pharmaceuticals Ltd. | 2.60% |
IDFC First Bank Ltd. | 2.16% |
Kei Industries Ltd. | 2.13% |
Bank of Maharashtra | 2.07% |
Nippon Life India Asset Management Ltd. | 2.04% |
APL Apollo Tubes Ltd. | 2.03% |
Name | Assets |
|---|---|
Prestige Estates Projects Ltd. | 7.33% |
Max Healthcare Institute Ltd. | 7.21% |
Meesho Ltd. | 5.42% |
The Federal Bank Ltd. | 5.37% |
Manipal Health Enterprises Ltd. | 4.44% |
Eternal Ltd. | 4.14% |
Global Health Ltd. | 3.97% |
L&T Finance Ltd. | 3.91% |
AU Small Finance Bank Ltd. | 3.81% |
Indusind Bank Ltd. | 3.51% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation & provide long-term growth opportunities by investing in a portfolio constituted of equity & equity related securities and derivatives predominantly in mid cap companies.
The scheme seeks to generate capital appreciation by investing predominantly in Mid cap entities.
Launch Date
08 Jan 2018
15 Feb 2007
